Río de Janeiro, BrasilECLA (Estudios Clínicos Latinoamérica) provides clinical monitoring and trials, pharmacology, and assistance with regulatory, financial, and legal affairs.

Av. Brazil, 4365 - Manguinhos, Rio de Janeiro - CEP: 21040-900To promote health and social development, to forge and disseminate scientific and technological knowledge, to be an agent of citizenship. These are the concepts that have guided Fundação Oswaldo Cruz (Oswaldo Cruz Foundation, known as Fiocruz), attached to the Brazilian Ministry of Health and the most prominent science and technology health institution in Latin America. Inaugurated on May 25, 1900 under the name of Federal Serotherapy Institute, Fiocruz was given the mission of fighting the great problems of public health in Brazil. Therefore, Fiocruz became a think tank concerned with the Brazilian reality and experimental medicine. Today the institution is responsible for a range of activities which include research development; highly-regarded hospital and ambulatory care services; production of vaccines, drugs, reagents, and diagnostic kits; education and training of human resources; information and communication in the area of health, science and technology; quality control of products and services, and the implementation of social programs. It has over 11,000 employees and health professionals with different levels of involvement, a workforce proud of being at the service of life.

Avenida Americo VespucioAt Parexel, speeding life-changing medicines to market begins by engaging patients With Heart™ With more than 24,000 life science professionals in 49 countries across six continents, Parexel’s people are the engine that drives clinical trial delivery, outcomes, and new medicines forward. We have made significant investment in our operations infrastructure to ensure consistent, predictable delivery all around the world as clinical research complexity continues to rise. Our trial execution framework integrates the latest innovations to efficiently manage increased research complexity, reach more patients while driving faster results for our customers and better outcomes for patients. And around the world, we’re investing today to develop a talent pool ready to deliver your next big breakthrough. The integration of clinical operations excellence and unparalleled regulatory consulting strength gives us an advantage when tackling the most complex trials in oncology, cell and gene therapies, rare diseases, and central nervous system disorders. We have a proven track record of strong performance in these areas, along with immunology, inflammation, and many more. We apply clinical operations and regulatory expertise to design clinical trials that help life-saving medicines reach patients sooner. From Phase I to Phase IV, global life sciences professionals work in partnership with biopharmaceutical sponsors to create trial experiences that are easier for patients to participate in and can serve as a viable care option for patients across a range of disease areas. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas while our innovation ecosystem offers solutions throughout the product lifecycle – optimising data quality, creating better clinical trial experiences, and improving operational efficiencies – with the goal of driving better results for our customers and outcomes for patients. With the people, insight, and operational excellence to support a thriving R&D community, Parexel works With HeartTM to treat patients with dignity and learn from their experiences, so every trial makes a difference. In 2021, Parexel was acquired by EQT and Goldman Sachs Asset Management. We are headquartered in Raleigh, North Carolina, and employ 20,815 professionals in 49 countries. We are united by a core value that we believe influences every aspect of our work: We Care. We care about our people, our customers, our sites, and our partners.

103 Rua Vaz da Costa Rio de Janeiro, 20760-510 BrazilStructured with the latest technology in equipment and engineering construction, Plast Labor operates in the laboratory market, hospitals and food, beverage, cosmetic and pharmaceutical since 1987. This year, we completed 25 years of production and dedication to the quality of our processes, evolving with the acquisition of knowledge, continued investment in technology and qualified personnel. Today Plast Labor has wide representation in the production of market ready means to use, with more than 500 products in this line. Investments were made for expansion of the existing plant, and further constructed a new unit for industrial manufacturing equipment with innovative ensuring the pioneer in full automation of manufacturing processes of culture media.